Use of Blood Biomarkers and Biomarker Index to Aid in the Diagnosis of Obstructive Sleep Apnea (OSA)

This multicenter prospective trial will evaluate the association between obstructive sleep apnea (OSA) and blood biomarkers in a representative population of consecutively enrolled symptomatic patients with a clinical suspicion of OSA.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Obstructive Sleep Apnea Apnea Dyssomnias Nervous System Diseases Respiration Disorders Respiratory Tract Diseases Sleep Apnea Syndromes Sleep Apnea, Obstructive Sleep Disorders, Intrinsic Sleep Wake Disorders

Age range

18 year–70 year

Sex eligibility

Male

Study type

Observational

Primary location

Sleep Center Orange County, Irvine, California, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Written Informed Consent
Male
18-70 years old
Presentation with symptoms suggestive of obstructive sleep apnea
Diagnostic sleep study
Blood draw

Exclusion criteria

Prior (within past year) or current therapy for sleep apnea
Use of opioid pain medication, steroids or allopurinol (within past 30 days)
Use of chronic anti-inflammatory drugs (within past 7 days)
Active cancer under current treatment or monitoring

Treatment and study plan

blood biomarker

Diagnostic Test

Primary outcomes

Identification of OSA in high-risk individuals

Time frame: 1 day

Identification of OSA in high-risk individuals

Sponsors and collaborators

Lead sponsor

Beckman Coulter, Inc.

Industry

Registry information

Important dates

Study start: 2016
Primary completion: 2017
Study completion: 2017
First posted: Apr 20, 2017
Registry last updated: Aug 18, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed